Press Information

The American Society of Nephrology (ASN) has released guidance on the outpatient management of patients with dialysis-requiring acute kidney injury (AKI-D) to aid clinicians in delivering the best care to foster recovery and identifying the early signs of possible recovery. The full report is published in the Journal of the American Society of Nephrology (JASN).

New guidance from the American Society of Nephrology (ASN) addresses needed improvements in providing appropriate care to patients discharged after experiencing acute kidney injury requiring in-hospital hemodialysis (AKI-D).

The American Society of Nephrology (ASN) has released its Kidney Health Guidance on the outpatient management of patients with dialysis-requiring acute kidney injury (AKI-D) to address the unique, individualized care needs of these patients.

In the aftermath of Hurricanes Irma and Maria, which struck the Caribbean in September 2017, the American Society of Nephrology was asked to provide logistical support to kidney care providers and patients with kidney diseases.

Obesity is an important health issue for patients with chronic kidney disease, speeding its progression, contributing to disability and limiting access to organ transplantation. Up to now, nephrologists typically do not manage obesity.

The Honor Our Living Donors or HOLD Act eliminates organ recipient income from consideration for certain reimbursements to living donors. The current cap on combined donor and recipient annual income is $53,000.

The American Society of Nephrology has championed a proposed bill to reinforce support and eligibility access for living organ donors, according to an association press release.

The demonstration project aims to increase kidney transplants by limiting discarded organs and encouraging living donations. Participation in the 6-year study is mandatory for 103 transplant centers.

ASN published guidance on managing obesity with kidney disease. Some kidney therapies may promote weight gain, and transplant often requires a weight cap. Psychosocial issues may present barriers to obesity care.

Michelle Josephson, MD University of Chicago Kidney Care Education and Policies: A National View from American Society of Nephrology CDRP 12th Annual Research Symposium Intersections of Policy, Innovation, Healthcare and Financialization for Kidney Disease: Where Are We in America Today?

The American Society of Nephrology (ASN) has released new kidney health guidance on the management of obesity in patients living with chronic kidney diseases (CKD) to help nephrologists, endocrinologists, primary care physicians, nurses, dietitians, and other professionals understand the tools available.

The American Society of Nephrology (ASN) has released its inaugural Kidney Health Guidance (KHG) on the Management of Obesity in Persons Living with Kidney Diseases, providing kidney health professionals and kidney care teams with knowledge on the existing tools for obesity management and guidance on implementation of these tools within clinical practice based on best available evidence and expert opinion. The guidance, 'ASN Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases', was published in the Journal of the American Society of Nephrology (JASN).

Sources of Healio | Nephrology News & Issues have made it clear that the explosive growth in the number of patients with end-stage kidney disease that join Medicare Advantage plans has overwhelmed everyone — payers and providers alike.

More than half of Black kidney transplant candidates have already benefited from a new race-neutral policy for estimating kidney function, according to recent national data.

The following is a joint Statement from the National Kidney Foundation (NKF) and American Society of Nephrology (ASN) on the Organ Procurement and Transplantation Network (OPTN) plans to remove the African American/Black race coefficient from the Kidney Donor Profile Index (KDPI) calculation.

In a move to improve kidney transplant equity, a new policy will remove a question about race from the Kidney Donor Profile Index because it "dishonors African American/Black donors."

The following is a joint Statement from the National Kidney Foundation (NKF) and American Society of Nephrology (ASN) on the Organ Procurement and Transplantation Network (OPTN) plans to remove the African American/Black race coefficient from the Kidney Donor Profile Index (KDPI) calculation.

The American Society of Nephrology (ASN) and Home Dialysis University (HDU) launched a collaboration in 2023 to improve nephrology trainees' knowledge, proficiency, and exposure to home dialysis therapies. Through the collaboration, ASN provided scholarships to 30 fellows to attend an in-person HDU fellows training course and participate in a virtual longitudinal case-based education series led by renowned experts in peritoneal and home hemodialysis. After a successful first year, ASN and HDU will continue the scholarship program this year, awarding 45 fellows the opportunity to participate in the program.

With a vulnerable population, centralized care, and a strong system in place for other shots, dialysis providers argue that they should be part of the early rollout with higher prioritization for their patients.

While staffers work to transfer patients as close to home as possible, with so many hospitals in Kansas beyond capacity, it has become more common than before to transfer as far away as Colorado and Nebraska.

In an interview with HCPLive®, Alan S. Kliger, MD, a clinical professor of medicine at the Yale University School of Medicine and co-chair of the American Society of Nephrology Covid-19 Response Team, explained it is essential that all nephrologists and accompanying medical personnel do their best to socially distance, wear masks, and get immunized for the flu.

In an interview with HCPLive®, Alan S. Kliger, MD, a clinical professor of medicine at the Yale University School of Medicine, explained how the kidneys of patients who did not previously suffer from kidney disease have been impacted by COVID-19.

Nephrologists examine the long-term effects of COVID-19 on the kidneys.

The novel coronavirus exposes another potential shortage in U.S. healthcare.

Although the novel coronavirus is known for causing respiratory symptoms, there are new questions about its impact on other parts of the body. COVID-19 may be linked in some patients with increases in inflammation of the heart as well as injury to other organs and tissues.

A surge in Covid-19 patients with kidney failure that is leading to shortages of machines, supplies and staff required for emergency dialysis.

Clinicians around the world are seeing evidence that suggests the virus also may be causing heart inflammation, acute kidney disease, neurological malfunction, blood clots, intestinal damage and liver problems.

Approximately 20 percent of coronavirus patients in intensive care around the city need the kidney treatment, often for weeks.

The negative impact of the COVID-19 pandemic on specialty medical practices may lift by the start of next month, according to a new report issued by the market research company Spherix Global Insights.

Care for the nation's 500,000 kidney dialysis patients, who routinely undergo treatment while packed together in group settings, is posing an especially difficult problem for physicians and experts planning for the anticipated surge of coronavirus cases.